Motivational interview-based health mediator interventions increase intent to vaccinate among disadvantaged individuals

Hum Vaccin Immunother. 2023 Aug;19(2):2261687. doi: 10.1080/21645515.2023.2261687. Epub 2023 Sep 29.

Abstract

Coverage for recommended COVID-19 and diphtheria-tetanus-poliomyelitis (DTP) booster shots is often inadequate, especially among disadvantaged populations. To help health mediators (HMs) involved in outreach programs deal with the problems of vaccine hesitancy (VH) in these groups, we trained them in motivational interviewing (MI). We evaluated the effectiveness of this training among HMs on their MI knowledge and skills (objective 1) and among the interviewees on their vaccination readiness (VR) and intention to get vaccinated or accept a booster against COVID-19 and/or DTP (objective 2). Two MI specialists trained 16 HMs in a two-day workshop in May 2022. The validated MISI questionnaire evaluated HMs' acquisition of MI knowledge and skills (objective 1). Trained HMs offered an MI-based intervention on vaccination to people in disadvantaged neighborhoods of Marseille (France). Those who consented completed a questionnaire before and after the interview to measure VR with the 7C scale and intentions regarding vaccination/booster against COVID-19 and DTP (objective 2). The training resulted in HMs acquiring good MI skills (knowledge, application, self-confidence in using it). HMs enrolled 324 interviewees, 96% of whom completed both questionnaires. VR increased by 6%, and intentions to get vaccinated or update COVID-19 and DTP vaccination increased by 74% and 52% respectively. Nearly all interviewees were very satisfied with the interview, although 21% still had questions about vaccination. HMs assimilated MI principles well. MI use in outreach programs appears to show promise in improving vaccine confidence and intentions among disadvantaged people.

Keywords: Vaccine readiness; disadvantaged populations; health mediation; motivational interviewing; vaccine hesitancy; vaccine intention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / prevention & control
  • Diphtheria-Tetanus Vaccine
  • Humans
  • Intention
  • Motivational Interviewing*
  • Vaccination
  • Vulnerable Populations

Substances

  • Diphtheria-Tetanus Vaccine

Grants and funding

This work was supported by the Regional Health Agency Provence-Alpes-Côte d’Azur (ARS PACA). This study is also part of the ICOVAC project labeled as National Research Priority by the National Orientation Committee for Therapeutic Trials and other researches on COVID-19 (CAPNET). The investigators would like to acknowledge ANRS | Emerging infectious diseases for their scientific support, the French Ministry of Health and Prevention and the French Ministry of Higher Education, Research and Innovation for their funding and support.